Difficulty: Medium
Average Score: 80%
Practice
A 41-year-old man with a history of gastroesophageal reflux disorder and diabetes mellitus is managed with cimetidine and diet/exercise for these disorders. The fact that he takes cimetidine means that the treating physician must be attune to increased effects of which of the following drugs?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Phenytoin. Cimetidine is a cytochrome P450 inhibitor, specifically CYP1A2 and CYP2C9. Phenytoin is primarily metabolized by CYP2C9, so the use of cimetidine can lead to increased levels of phenytoin in the body. This interaction can potentially result in phenytoin toxicity, leading to adverse effects.
Option A) Dronabinol is primarily metabolized by CYP2C9 and CYP3A4, not significantly affected by cimetidine.
Option B) Erythromycin is a substrate of CYP3A4 and is not significantly impacted by cimetidine's inhibition of CYP1A2 and CYP2C9.
Option C) Ketoconazole is a strong inhibitor of CYP3A4 but not directly related to the enzymes affected by cimetidine.
Educationally, understanding drug interactions is crucial in clinical practice to prevent adverse effects and ensure optimal patient outcomes. Healthcare providers must be aware of potential interactions between medications to make informed decisions when managing patients with multiple comorbidities and complex medication regimens.
Option A) Dronabinol is primarily metabolized by CYP2C9 and CYP3A4, not significantly affected by cimetidine.
Option B) Erythromycin is a substrate of CYP3A4 and is not significantly impacted by cimetidine's inhibition of CYP1A2 and CYP2C9.
Option C) Ketoconazole is a strong inhibitor of CYP3A4 but not directly related to the enzymes affected by cimetidine.
Educationally, understanding drug interactions is crucial in clinical practice to prevent adverse effects and ensure optimal patient outcomes. Healthcare providers must be aware of potential interactions between medications to make informed decisions when managing patients with multiple comorbidities and complex medication regimens.